Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology (Q36811537)

16 August 2017

1 reference

title

Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology (English)

1 reference

16 August 2017

0 references

1 reference

1 reference

Georg B Ehret

1 reference

16 August 2017

Jules A Desmeules

series ordinal

1 reference

16 August 2017

Barbara Broers

series ordinal

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Expert Opinion on Drug Safety

16 August 2017

published in

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

16 August 2017

page(s)

289-303

1 reference

Über eine neue Klasse von spasmolytisch und analgetisch wirkenden Verbindungen, I

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Treating opioid dependence. Growing implications for primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Torsade de pointes associated with very-high-dose methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

The effect of heroin and multiple drug abuse on the electrocardiogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Stereoselective pharmacokinetics of methadone in chronic pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Bioavailabilities of rectal and oral methadone in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Methadone plasma level: sustained by a reservoir of drug in tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Identification and functional characterization of eight CYP3A4 protein variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Drug-induced prolongation of the QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Fatal quinine cardiotoxicity in the treatment of falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Inhibition of HERG potassium channels by cocaethylene: a metabolite of cocaine and ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Hepatitis C morbidity is set to double in next decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Methadone in the management of cancer pain: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Methadone-induced respiratory depression in a patient with a history of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Methadone and fluconazole: respiratory depression by drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Refining detection of drug-induced proarrhythmia: QT interval and TRIaD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

The molecular genetics of the long QT syndrome: genes causing fainting and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Drug-induced torsade de pointes. Incidence, management and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

The long QT syndrome: a prospective international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

HERG K+ channels: friend and foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Cardiac actions of erythromycin: influence of female sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Molecular predictors of drug-induced prolongation of the QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Death attributed to methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

QTc interval prolongation associated with intravenous methadone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Interactions of the narcotic l-alpha-acetylmethadol with human cardiac K+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Methadone use in cancer patients with pain: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

The impact of methadone induction on cardiac conduction in opiate users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Impact of methadone treatment on cardiac repolarization and conduction in opioid users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

QTc interval prolongation in patients on long-term methadone maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Inheritance and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Pharmacogenomics: unlocking the human genome for better drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

A SNPshot: pharmacogenetics and the future of drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Genetic susceptibility to adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Mutations in the hminK gene cause long QT syndrome and suppress lKs function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Molecular basis of the long-QT syndrome associated with deafness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

KCNE1 mutations cause Jervell and Lange-Nielsen syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Sudden death associated with short-QT syndrome linked to mutations in HERG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Molecular mechanism for an inherited cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Multiple mechanisms of Na+ channel--linked long-QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Genetic basis and molecular mechanism for idiopathic ventricular fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

A cardiac arrhythmia syndrome caused by loss of ankyrin-B function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Qt prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

A twist on torsade: a prolonged QT interval on methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

QT prolongation and syncope with methadone, doxepin, and a beta-blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Cytochrome P450 2D6 Genotype and Methadone Steady-State Concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.289

21 January 2018

Identifiers

DOI

10.1517/14740338.6.3.289

1 reference

16 August 2017

1 reference